Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Hirsutism causes significant psychological distress in women.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.